UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 557

Sortiert nach

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Journal of clinical oncology, 2015-08, Vol.33 (24), p.2617-2622

2015

Volltextzugriff (PDF)

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Journal of clinical oncology, 2012-01, Vol.30 (3), p.263-267

2012

Volltextzugriff (PDF)

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Journal of clinical oncology, 2011-11, Vol.29 (31), p.4105-4112

2011

Volltextzugriff (PDF)

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

Journal of clinical oncology, 2013-10, Vol.31 (29), p.3664-3672

2013

Volltextzugriff (PDF)

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Annals of surgical oncology, 2013-08, Vol.20 (8), p.2787-2795

2013

Volltextzugriff (PDF)

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

Journal of clinical oncology, 2007-04, Vol.25 (12), p.1539-1544

2007

Volltextzugriff (PDF)

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

Clinical cancer research, 2014-06, Vol.20 (11), p.3033-3043

2014

Volltextzugriff (PDF)

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

JNCI : Journal of the National Cancer Institute, 2014-07, Vol.106 (7), p.1

2014

Volltextzugriff (PDF)

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

Clinical cancer research, 2015-12, Vol.21 (23), p.5294-5304

2015

Volltextzugriff (PDF)

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

Scientific reports, 2017-03, Vol.7 (1), p.43393-43393, Article 43393

2017

Volltextzugriff (PDF)

Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study

Journal of clinical oncology, 2005-12, Vol.23 (36), p.9243-9249

2005

Volltextzugriff (PDF)

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Journal of clinical oncology, 2004-01, Vol.22 (1), p.23-30

2004

Volltextzugriff (PDF)

Gastric cancer in Alaska Native people: A cancer health disparity

World journal of gastroenterology : WJG, 2018-07, Vol.24 (25), p.2722-2732

2018

Volltextzugriff (PDF)

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Journal of clinical oncology, 2011-02, Vol.29 (4), p.421-427

2011

Volltextzugriff (PDF)

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

European journal of surgical oncology, 2018-05, Vol.44 (5), p.677-683

2018

Volltextzugriff (PDF)

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

Gastrointestinal endoscopy, 2017-07, Vol.86 (1), p.161-169

2017

Volltextzugriff (PDF)

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

JNCI : Journal of the National Cancer Institute, 2014-12, Vol.106 (12), p.1

2014

Volltextzugriff (PDF)

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Journal of clinical oncology, 2004-05, Vol.22 (10), p.1797-1806

2004

Volltextzugriff (PDF)

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

Mayo Clinic proceedings, 2016-01, Vol.91 (1), p.61-70

2016

Volltextzugriff (PDF)

Combined Modality Therapy Including Intraoperative Electron Irradiation for Locally Recurrent Colorectal Cancer

International journal of radiation oncology, biology, physics, 2011, Vol.79 (1), p.143-150

2011

Volltextzugriff (PDF)

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

Clinical gastroenterology and hepatology, 2019-03, Vol.17 (4), p.728-738.e9

2019

Volltextzugriff (PDF)

Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147

Journal of clinical oncology, 2013-06, Vol.31 (16), p.2016-2023

2013

Volltextzugriff (PDF)

Molecular Classification of Gastric Cancer among Alaska Native People

Cancers, 2020-01, Vol.12 (1), p.198

2020

Volltextzugriff (PDF)

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

The oncologist (Dayton, Ohio), 2014-05, Vol.19 (5), p.492-497

2014

Volltextzugriff (PDF)

1 – 25 von 557

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(531)
Mit Volltextzugriff
(485)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(384)
Life Sciences & Biomedicine
(370)
Humans
(352)
Female
(224)
Male
(211)
Middle Aged
(174)
Aged
(166)
Oncology
(159)
Adult
(138)
Biological And Medical Sciences
(112)
Medical Sciences
(111)
Treatment Outcome
(86)
Aged, 80 And Over
(78)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(64)
Tumors
(62)
Neoplasm Staging
(43)
Prospective Studies
(42)
Chemotherapy
(41)
Clinical Trials
(41)
Gastroenterology. Liver. Pancreas. Abdomen
(40)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Clinical Oncology
(105)
Cancer
(15)
Clinical Cancer Research
(15)
Jnci : Journal Of The National Cancer Institute
(14)
Cell Reports
(13)
Clinical Colorectal Cancer
(12)
The New England Journal Of Medicine
(11)
Cancer Research
(9)
Cell
(9)
Innovation In Aging
(9)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

SWOG S0809: A Phase II Intergroup Trial of Adjuvant Capecitabine and Gemcitabine Followed by Radiotherapy and Concurrent Capecitabine in Extrahepatic Cholangiocarcinoma and Gallbladder Carcinoma

Treatment of Colorectal Peritoneal Carcinomatosis With Systemic Chemotherapy: A Pooled Analysis of North Central Cancer Treatment Group Phase III Trials N9741 and N9841

Gemcitabine Alone Versus Gemcitabine Plus Radiotherapy in Patients With Locally Advanced Pancreatic Cancer: An Eastern Cooperative Oncology Group Trial

Prognostic Impact of Deficient DNA Mismatch Repair in Patients With Stage III Colon Cancer From a Randomized Trial of FOLFOX-Based Adjuvant Chemotherapy

Borderline Resectable Pancreatic Cancer: Need for Standardization and Methods for Optimal Clinical Trial Design

Bevacizumab in Combination With Oxaliplatin, Fluorouracil, and Leucovorin (FOLFOX4) for Previously Treated Metastatic Colorectal Cancer: Results From the Eastern Cooperative Oncology Group Study E3200

KRAS Codon 12 and 13 Mutations in Relation to Disease-Free Survival in BRAF-Wild-Type Stage III Colon Cancers from an Adjuvant Chemotherapy Trial (N0147 Alliance)

Patient and Tumor Characteristics and BRAF and KRAS Mutations in Colon Cancer, NCCTG/Alliance N0147

Analysis of Molecular Markers by Anatomic Tumor Site in Stage III Colon Carcinomas from Adjuvant Chemotherapy Trial NCCTG N0147 (Alliance)

MiR-139-5p as a novel serum biomarker for recurrence and metastasis in colorectal cancer

Oxaliplatin, Fluorouracil, and Leucovorin for Patients With Unresectable Liver-Only Metastases From Colorectal Cancer: A North Central Cancer Treatment Group Phase II Study

A Randomized Controlled Trial of Fluorouracil Plus Leucovorin, Irinotecan, and Oxaliplatin Combinations in Patients With Previously Untreated Metastatic Colorectal Cancer

Gastric cancer in Alaska Native people: A cancer health disparity

Intravenous Calcium and Magnesium for Oxaliplatin-Induced Sensory Neurotoxicity in Adjuvant Colon Cancer: NCCTG N04C7

Prognostic factors and benefits of adjuvant therapy after pancreatoduodenectomy for ampullary adenocarcinoma: Mayo Clinic experience

Antitumor effect of FGFR inhibitors on a novel cholangiocarcinoma patient derived xenograft mouse model endogenously expressing an FGFR2-CCDC6 fusion protein

EUS-guided fine-needle injection of gemcitabine for locally advanced and metastatic pancreatic cancer

ACCENT-Based Web Calculators to Predict Recurrence and Overall Survival in Stage III Colon Cancer

Pooled Analysis of Fluorouracil-Based Adjuvant Therapy for Stage II and III Colon Cancer: Who Benefits and by How Much?

Stool DNA Testing for Screening Detection of Colorectal Neoplasia in Alaska Native People

Combined Modality Therapy Including Intraoperative Electron Irradiation for Locally Recurrent Colorectal Cancer

Combined Celiac Ganglia and Plexus Neurolysis Shortens Survival, Without Benefit, vs Plexus Neurolysis Alone

Associations Between Cigarette Smoking Status and Colon Cancer Prognosis Among Participants in North Central Cancer Treatment Group Phase III Trial N0147

Molecular Classification of Gastric Cancer among Alaska Native People

Prospective Multicenter Study of the Impact of Oncotype DX Colon Cancer Assay Results on Treatment Recommendations in Stage II Colon Cancer Patients

Suchergebnisse filtern